Infographic: One Big Beautiful Bill Act (OBBBA) readiness

As the healthcare industry prepares for the implementation of the One Big Beautiful Bill Act (OBBBA), it’s clear that readiness is not one-size-fits-all. Hospitals are leading the way, but most providers will need focused updates to their Medicaid/Medicare processes to ensure compliance and protect revenue. In October 2025, Experian Health surveyed 200 healthcare decision-makers to get…

Read More

Ventyx Bio Cardiovascular Drug’s Phase 2 Results Set Up Talks With a Big Pharma Firm

An experimental Ventyx Biosciences drug led to statistically significant reductions in blood levels of a protein that’s an indicator of cardiovascular risk, preliminary Phase 2 results that support this molecule’s approach of addressing what is becoming a competitive inflammation target for heart disease. The data readout also starts the clock on negotiations with a big…

Read More